Data analytics in pharmaceutical supply chains: state of the art, opportunities, and challenges
通过系统文献综述，梳理了2012至2021年间制药供应链数据分析的研究现状、机遇与挑战，提出了评估框架，指出机器学习在解决药品短缺和库存优化方面有前景，但非结构化数据利用不足。
In recent years, data analytics in pharmaceutical supply chains has aroused much interest as it has the potential of enabling better supply and management of healthcare products by leveraging data generated by modern systems. This article presents the current state, opportunities, and challenges of data analytics in pharmaceutical supply chains through a systematic literature review surveying the Scopus, ScienceDirect, and Springerlink databases. 85 publications from 2012 to 2021 were reviewed and classified based on the research approach, objective addressed, and data used. The contributions of this paper are threefold: (i) it proposes a framework focused on challenges and data resources to assess the current state of data analytics in pharmaceutical supply chains; (ii) it provides examples of techniques exemplified that will serve as inspiring references; and (iii) it gathers and maps existing literature to identify gaps and research perspectives. Findings outlined that despite promising results from machine learning algorithms to address drug shortages and inventories optimisation, the various data resources have not yet been fully harnessed. Unstructured data have barely been used and combined with other types of information. New challenges related to green practices adoption and medicines supply during crises call for further applications of advanced analytics techniques.